Kawakami, Y <br/><br/>
Pharmacokinetics, efficacy and safety of daclatasvir plus asunaprevir in dialysis patients with chronic hepatitis C: pilot study.  [electronic resource] 

 -  Journal of viral hepatitis  11 2016 
 - 850-856 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1365-2893 
<br/><br/><label>Standard No.: </label>10.1111/jvh.12553  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Antiviral Agents--administration & dosage<br/>Carbamates<br/>Drug-Related Side Effects and Adverse Reactions--epidemiology<br/>Female<br/>Hepatitis C, Chronic--drug therapy<br/>Humans<br/>Imidazoles--administration & dosage<br/>Incidence<br/>Isoquinolines--administration & dosage<br/>Male<br/>Middle Aged<br/>Pilot Projects<br/>Prospective Studies<br/>Pyrrolidines<br/>Renal Dialysis<br/>Renal Insufficiency--complications<br/>Sulfonamides--administration & dosage<br/>Sustained Virologic Response<br/>Treatment Outcome<br/>Valine--analogs & derivatives